RFP
IOVA icon

Root Financial Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Root Financial Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200 Buy
+57
New +$182 ﹤0.01% 3156

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Root Financial Partners's IOVA Position: Q1 2026 in Review

Root Financial Partners opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2026: 57 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #3156 among its holdings.

285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Root Financial Partners held 57 shares of Iovance Biotherapeutics worth $200 as of Q1 2026.
  • Iovance Biotherapeutics was a new Root Financial Partners position in Q1 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3156 holding.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.